Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study

Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study

Introduction: Although pretreatment autoantibodies have been associated with immune-related adverse events (irAEs) and immune checkpoint inhibitor treatment efficacy in some types of cancer, their importance has not been evaluated in patients with SCLC. Methods: A multicenter prospective observation...

Full description

Bibliographic Details
Main Authors: Yuki Sato, MD, Satoru Fujiwara, MD, Akito Hata, MD, Yoko Kida, MD, Takahiro Masuda, MD, Hisanori Amimoto, MD, Hirotaka Matsumoto, MD, Kotoko Miyoshi, MD, Kojiro Otsuka, MD, PhD, Keisuke Tomii, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:JTO Clinical and Research Reports
Subjects:
Small-cell lung cancer
Immune-related adverse event
Autoantibody
Paraneoplastic autoantibody
Paraneoplastic neurologic syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323001510

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323001510

Similar Items